SGLT2 Inhibition and Atrial Fibrillation: Faint Light at the End of the Tunnel
- PMID: 36424009
- DOI: 10.1016/j.jacep.2022.09.006
SGLT2 Inhibition and Atrial Fibrillation: Faint Light at the End of the Tunnel
Keywords: atrial fibrillation; catheter ablation; diabetes mellitus; sodium-glucose cotransporter 2 inhibitors.
Conflict of interest statement
Funding Support and Author Disclosures Dr Wazni is a consultant to Biosense Webster and Boston Scientific. Dr Younis has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation.JACC Clin Electrophysiol. 2022 Nov;8(11):1393-1404. doi: 10.1016/j.jacep.2022.08.004. Epub 2022 Oct 26. JACC Clin Electrophysiol. 2022. PMID: 36424008 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical